(SIMH) Sells Almost 100 Caregiver(R) TouchFree(TM) Clinical Thermometers To Fight #Ebola

MIAMI, Oct. 10, 2014 — Sanomedics International Holdings, Inc. (OTCQB:SIMH); “Sanomedics” or the “Company”); a medical technology holding company that focuses on providing game changing products, services and ideas, announced today that the Company’s Thermomedics, Inc. division has shipped the first group of devices to Atlanta Headquarters of the Center for Disease Control (“CDC”) for immediate distribution to selected ports of entry, where touch-free temperatures are destined to identify fevers in arriving travelers from at-risk countries.

Keith Houlihan, President of Sanomedics, noted that “Caregiver TouchFree™ Thermometers are uniquely suited to this type of highly infectious virus, since the method of transfer is via contact with body fluids and contaminated substances from the victims.”

He added that “Thermomedics is pleased to be able to supply this revolutionary instrument for use in the battle against the current threat to the nation’s health and security. Using no probe covers and patient contact means that there is less contaminated waste attributable to the temperature screening process.”

During a television interview Thursday on Miami’s local Fox affiliate WSVN, Houlihan mentioned that authorities have been quick to recognize the technology’s accuracy, safety, and strong clinical documentation.

Thermomedics’ VP of Marketing and Sales, Ron Benincasa, indicated that the speed of the process (1-2 seconds), simplicity of technique (point and press one button), and protection of the temperature-takers make this an ideal tool in this urgent effort.

The Company has dramatically increased production requirements to meet the escalating demand for the Caregiver, not only for the CDC needs, but in response to the growing adoption of these devices in healthcare facilities across the United States.

About Sanomedics International Holdings, Inc.

Sanomedics International Holdings, Inc. (OTCQB:SIMH) is a medical technology holding company that focuses on game changing products, services and ideas — a place where physicians, entrepreneurs, and medical companies can work together to drive innovative technologies through concept, development, and ultimately commercialization. Sanomedics plans to grow existing business organically and through strategic acquisitions specifically relating to healthcare technology and services.

Make sure you are first to receive timely up-to-date information on Sanomedics and its subsidiaries. Sign up for Sanomedics email news alert system today at: http://ir.stockpr.com/sanomedics/email-alerts.

Also be sure to follow Sanomedics on Twitter https://twitter.com/sanomedics and tweet us (@Sanomedics) your questions and comments. We would love to hear from you!

Forward Looking Statements

This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties (for example, the risk that the acquisition is not consummated), and that actual results may differ materially from those in the forward-looking statements as a result of various factors. The Company’s periodic filings with the Securities and Exchange Commission should be viewed for a complete understanding of risk and uncertainty.

CONTACT: Keith Houlihan
         info@Sanomedics.com
         305-433-7814